12th Conference of the European Hidradenitis Suppurativa Foundation e.V. - EHSF 2023
8 Février 2023 · 3 joursFlorence, hybrid, ItalieDermatologie et VénérologieAnglais
Florence, hybridÀ propos de ce congrès
We are glad and proud to welcome you in the city of Florence for the 12th Conference of the European Hidradenitis Suppurativa Foundation and to warmly welcome all the participants via web.
Hidradenitis Suppurativa (HS) is a chronic inflammatory debilitating skin disease with a very heavy impact on quality of life. Until 2006 it has been considered an orphan disease, due to its limited knowledge and also to the great diagnostic delay. An important progress has been made in the last decade concerning its correct and earlier diagnosis and therapeutical approaches. Even though a lot has been done, there is current evidence that the measurements and the therapeutical tools are not able to fulfil the needs of HS patients. Moreover, it is necessary to increase the centrality of the patient in clinical research to get HS patients involved in their own treatment.
Hidradenitis Suppurativa (HS) is a chronic inflammatory debilitating skin disease with a very heavy impact on quality of life. Until 2006 it has been considered an orphan disease, due to its limited knowledge and also to the great diagnostic delay. An important progress has been made in the last decade concerning its correct and earlier diagnosis and therapeutical approaches. Even though a lot has been done, there is current evidence that the measurements and the therapeutical tools are not able to fulfil the needs of HS patients. Moreover, it is necessary to increase the centrality of the patient in clinical research to get HS patients involved in their own treatment.
MEDFLIXS couvrira les temps forts de ce congrès sous forme d'interviews vidéo et de best-of disponibles pour les professionnels de santé inscrits.